Carney Lloyd's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Jan 31, 2023
- Accession no.
- 0001209191-23-005717
- Filed
- Jan 31, 2023
- Trade date
- Jan 30, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $865.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carney LloydCIK 0001204424 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Common Stock | SSaleDisposed | −1,376 | $320.08F2,F3 | −$440,430.08 | 5,474 | Direct | |
| Jan 30, 2023 | Common Stock | SSaleDisposed | −1,000 | $320.70F2,F4 | −$320,700 | 4,474 | Direct | |
| Jan 30, 2023 | Common Stock | SSaleDisposed | −324 | $321.84F2,F5 | −$104,276.16 | 4,150 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $320.08 (range $319.40 to $320.38).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $320.70 (range $320.43 to $321.31).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $321.84 (range $321.54 to $322.23).
Referenced by the price of 1 transaction in Table I.